Niven R. Narain is Co-Founder, President & CEO of Berg, a Boston-based biopharma company housing fully integrated discovery, clinical, analytics, and diagnostics divisions. Narain is keenly focused on making the healthcare industry more efficient by employing the flagship Interrogative Biology® platform he created which leverages leading-edge biological and clinical insight from patients. The platform merges biology with technology to represent a true Precision Medicine approach to understating patient populations with use of AI to derive actionable drug targets, biomarkers, and health analytic information.